Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2009 Oct 1.

Published in final edited form as: Int J Radiat Oncol Biol Phys. 2008 Oct 1;72(2):610–616. doi: 10.1016/j.ijrobp.2008.06.1488

Table 3.

Comparison of average mean (or maximum) doses (Gy, ±σ), delivered with a static-based IMRT plan, with varying patient motion.

Target/OAR^*	Dose (Gy) ± Standard deviation
Target/OAR^*	Immobilized at End Exhale	Normal Respiration	Deep Respiration
Boost	60.4 ± 0.2	57.7 ± 7.0 (p = 0.31)	59 ± 2.5 (p = 0.14)
Breast	52.3 ± 1.4	50.2 ± 6.9 (p = 0.36)	51.5 ± 2.3 (p = 0.37)
SCV^§	52.4 ± 0.9	52.6 ± 0.8 (p = 0.23)	52.6 ± 0.9 (p = 0.25)
ICV^†	53.1 ± 0.5	53 ± 0.7 (p = 0.32)	52.6 ± 1.2 (p = 0.19)
IMN^††	50.8 ± 3.9	48 ± 9.8 (p = 0.35)	49.8 ± 3.9 (p = 0.30)
Heart	0.7 ± 0.7	0.8 ± 0.8 (p = 0.10)	0.9 ± 0.9 (p = 0.04)
Heart (Max)	9.3 ± 8.4	10.8 ± 8.7 (p = 0.07)	13.5 ± 9.0 (p = 0.01)
LAD^{[ ]}	2.5 ± 2.2	2.5 ± 2.0 (p = 0.89)	3.5 ± 2.4 (p = 0.003)
LAD (Max)	11.6 ± 7.6	13.2 ± 6.9 (p = 0.37)	17.4 ± 7.7 (p = 0.01)
Ipsilateral lung	11.9 ± 1.8	11.2 ± 2.6 (p = 0.53)	13 ± 2.1 (p = 0.04)

^*

Abbreviations: Organs at Risk;

^§

Supraclavicular Lymph Nodes;

^†

Infraclavicular Lymph Nodes;

^††

Internal Mammary Lymph Nodes;

^{[ ]}

Left Anterior Descending Artery